Trials / Completed
CompletedNCT00138866
Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury
Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Toronto Rehabilitation Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out if risedronate works for the treatment of osteoporosis for people with spinal cord injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risedronate |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2009-01-01
- Completion
- 2009-03-01
- First posted
- 2005-08-30
- Last updated
- 2010-10-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00138866. Inclusion in this directory is not an endorsement.